• FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
• Legislative: FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Regulatory: Prioritize kidney health research, including inside the NIH

Duration: July 1, 2008 to present

General Issues: Health Issues, Science/Technology, Disaster Planning/Emergencies, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Medicare/Medicaid

Spending: about $1,721,286 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Homeland Security - Dept of (DHS), Federal Emergency Management Agency (FEMA), Veterans Affairs - Dept of (VA), White House Office, Office of Management & Budget (OMB), Defense Advanced Research Projects Agency (DARPA), Health & Human Services - Dept of (HHS), Natl Aeronautics & Space Administration (NASA), House of Representatives,, Centers For Medicare and Medicaid Services (CMS), Agency for Health Care Policy & Research, Food & Drug Administration (FDA)